Klemens Budde

33.8k total citations · 4 hit papers
610 papers, 17.7k citations indexed

About

Klemens Budde is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Klemens Budde has authored 610 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 379 papers in Transplantation, 155 papers in Surgery and 124 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Klemens Budde's work include Renal Transplantation Outcomes and Treatments (378 papers), Organ Transplantation Techniques and Outcomes (104 papers) and Neurological Complications and Syndromes (95 papers). Klemens Budde is often cited by papers focused on Renal Transplantation Outcomes and Treatments (378 papers), Organ Transplantation Techniques and Outcomes (104 papers) and Neurological Complications and Syndromes (95 papers). Klemens Budde collaborates with scholars based in Germany, United States and Spain. Klemens Budde's co-authors include Lutz Fritsche, Hans‐Hellmut Neumayer, Johannes Waiser, Petra Glander, Lutz Liefeldt, Fabian Halleck, Susanne Brakemeier, Birgit Rudolph, Danilo Schmidt and Duska Dragun and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Klemens Budde

586 papers receiving 17.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

2005 638 citations Klemens Budde, Hans‐Hellmut Neumayer et al. profile →
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

2013 629 citations Susanne Brakemeier, Klemens Budde et al. profile →
Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

2007 468 citations Flavio Vincenti, Lionel Rostaing et al. American Journal of Transplantation profile →
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

2023 95 citations Ajit P. Limaye, Klemens Budde et al. JAMA profile →

Peers

Countries citing papers authored by Klemens Budde

Since Specialization

Citations

This map shows the geographic impact of Klemens Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klemens Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klemens Budde more than expected).

Fields of papers citing papers by Klemens Budde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klemens Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klemens Budde. The network helps show where Klemens Budde may publish in the future.

Co-authorship network of co-authors of Klemens Budde

This figure shows the co-authorship network connecting the top 25 collaborators of Klemens Budde. A scholar is included among the top collaborators of Klemens Budde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klemens Budde. Klemens Budde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments 2024 ·Acta Physiologica ·(unknown), (unknown), Carsten Dittmayer, Duygu Elif Yılmaz, (unknown), Michael Mülleder, Christian Hinze, (unknown), Philipp Mertins, Marieluise Kirchner, Bilgin Osmanodja, Alexander Paliege, Klemens Budde, Kerstin Amann, Pontus B. Persson, Kerim Mutig, Sebastian Bachmann	7
2	Retrospective analysis of the perioperative outcome in living donor kidney transplantation with multiple renal arteries: does accessory vessel ligation affect the outcome? 2024 ·World Journal of Urology ·(unknown), Robert W. Peters, (unknown), Bernhard Ralla, (unknown), (unknown), Lutz Liefeldt, Klemens Budde, Markus Herbert Lerchbaumer, Frank Friedersdorff	0
3	Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications 2024 ·Transplant International ·(unknown), Klemens Budde, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, Bilgin Osmanodja	1
4	Prospectively investigating the impact of AI on shared decision-making in post kidney transplant care (PRIMA-AI): protocol for a longitudinal qualitative study among patients, their support persons and treating physicians at a tertiary care centre 2024 ·BMJ Open ·(unknown), (unknown), Roland Roller, Bilgin Osmanodja, Aljoscha Burchardt, (unknown), Peter Dabrock, Sebastian Möller, Klemens Budde, Anne Herrmann	2
5	Kidney transplantation in patients with polycystic kidney disease: increased risk of infection does not compromise graft and patient survival 2024 ·Clinical Kidney Journal ·Johannes Waiser, Jens Klotsche, Petra Glander, (unknown), Marcel G. Naik, Lutz Liefeldt, Klemens Budde, Jan Halbritter, Fabian Halleck, Bianca Zukunft, Robert W. Peters, Frank Friedersdorff, Nils Lachmann, Kai‐Uwe Eckardt, (unknown), Friederike Bachmann	1
6	Pregnancy after Kidney Transplantation—Impact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity of Immunosuppression on Kidney Function and Maternal Health 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Friederike Bachmann, Nils Lachmann, Nadine Koch, Bianca Zukunft, Kaiyin Wu, Danilo Schmidt, Fabian Halleck, Peter Nickel, Kai‐Uwe Eckardt, Klemens Budde, Stefan Verlohren, Mira Choi	4
7	Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients breakdown → 2023 ·JAMA ·Ajit P. Limaye, Klemens Budde, Atul Humar, Flavio Vincenti, Dirk Kuypers, Robert Carroll, Nicole Stauffer, Yoshihiko Murata, Julie Strizki, Valerie Teal, Christopher L. Gilbert, Barbara Haber	95
8	Shear Wave Elastography for Assessing Liver Stiffness in HCV-Infected Kidney Transplant Recipients after Direct-Acting Antiviral Treatment: A Comparative Study with Magnetic Resonance Elastography 2023 ·Journal of Clinical Medicine ·(unknown), Fabian Halleck, Michael Dürr, Ulrike Grittner, Eva Schrezenmeier, Klemens Budde, Christian E. Althoff, Bernd Hamm, Ingolf Sack, Thomas Fischer, Stephan Rodrigo Marticorena Garcia	1
9	#4233 FIXED LOW DOSE VERSUS CONCENTRATION-CONTROLLED INITIAL TACROLIMUS DOSING: RESULTS FROM A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (SLOW&LOW STUDY) 2023 ·Nephrology Dialysis Transplantation ·Julian Stumpf, Klemens Budde, Oliver Witzke, Claudia Sommerer, Thomas Vogel, Peter Schenker, Rainer P. Woitas, (unknown), Evelyn Trips, Eva Schrezenmeier, Christian Hugo	1
10	Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation 2023 ·Kidney International Reports ·(unknown), Klemens Budde, Mira Choi, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, (unknown), Bilgin Osmanodja	2
11	Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial 2022 ·Trials ·Katharina A. Mayer, Klemens Budde, Philip F. Halloran, Konstantin Doberer, Lionel Rostaing, Farsad Eskandary, (unknown), Markus Wahrmann, Heinz Regele, Sabine Schranz, Sarah Ely, Christa Firbas, Christian Schörgenhofer, Alexander Kainz, Alexandre Loupy, Stefan Härtle, Rainer Boxhammer, Bernd Jilma, Georg A. Böhmig	15
12	Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial 2022 ·American Journal of Transplantation ·Amelie Kurnikowski, (unknown), Elisabeth Schwaiger, (unknown), Jürgen Harreiter, Alexandra Kautzky‐Willer, Michael Leutner, Johannes Werzowa, Andrea Tura, Klemens Budde, Kathrin Eller, Julio Pascual, Michael Krebs, Trond Jenssen, Manfred Hecking	10
13	B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients 2021 ·Journal of the American Society of Nephrology ·Eva Schrezenmeier, Héctor Rincón-Arévalo, Ana‐Luisa Stefanski, (unknown), (unknown), Mira Choi, Friederike Bachmann, (unknown), (unknown), Hubert Schrezenmeier, Carolin Ludwig, Bernd Jahrsdörfer, Andreia C. Lino, Kai‐Uwe Eckardt, Katja Kotsch, Thomas Dörner, Klemens Budde, Arne Sattler, Fabian Halleck	61
14	Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas–Kidney Transplantation (SPKT)—A Landmark Analysis 2021 ·Journal of Clinical Medicine ·Lukas Lehner, Robert Öllinger, Brigitta Globke, Marcel G. Naik, Klemens Budde, Johann Pratschke, Kai‐Uwe Eckardt, Andreas Kahl, Kun Zhang, Fabian Halleck	7
15	Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism 2021 ·Transplant International ·Jakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer, Michael Dürr, Klemens Budde, Farsad Eskandary, Katharina A. Mayer, Sabine Schranz, Sarah Ely, Birgit Reiter, Edward Chong, Scott Adler, Bernd Jilma, Georg A. Böhmig	7
16	Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging 2020 ·American Journal of Transplantation ·Philip F. Halloran, Georg A. Böhmig, Jonathan S. Bromberg, Klemens Budde, Gaurav Gupta, Gunilla Einecke, Farsad Eskandary, Katelynn S. Madill-Thomsen, J. Reeve	7
17	Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR) 2019 ·PLoS ONE ·Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Timo Räth, Robert A. Schuhmann, Bianca Zukunft, (unknown), Martina Porstner, Klemens Budde	8
18	A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients 2019 ·BMC Nephrology ·Michael Duerr, Eva Schrezenmeier, Lukas Lehner, Léon Bergfeld, Petra Glander, Stephan Rodrigo Marticorena Garcia, Christian E. Althoff, Ingolf Sack, Susanne Brakemeier, Kai‐Uwe Eckardt, Klemens Budde, Fabian Halleck	7
19	INTERNATIONAL, MATCHED-COHORT CHECKERBOARD STUDY OF QUALITY OF LIFE AND DISEASE BURDEN IN KIDNEY TRANSPLANT (TX) PATIENTS WITH ANTIBODY-MEDIATED REJECTION (AMR) 2019 ·Transplant International ·Titus Augustine, John S. Gill, Klemens Budde, (unknown), James H. Lan, Michael Duerr, Ishan Hirji, Zoltán Kaló, Giovanna Devercelli, Paul Keown	1
20	D3 Immunosuppression - other (T688 - T710) 2003 ·Nephrology Dialysis Transplantation ·(unknown), Andreas Link, Matthias Girndt, Georg Nickenig, Michael Böhm, Hans Köhler, Johannes Waiser, (unknown), Klemens Budde, Hans‐Hellmut Neumayer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact